Detalhe da pesquisa
1.
Phenotypic Consequences of SLC25A40-ABCB1 Fusions beyond Drug Resistance in High-Grade Serous Ovarian Cancer.
Cancers (Basel)
; 13(22)2021 Nov 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34830797